San Jose, CA, June 23, 2016 --(PR.com
)-- The latest market report published by Credence Research, Inc. “Global Novel Drug Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the Novel Drug Delivery Systems (NDDS) market was valued at USD 165.4 Bn and is expected to reach USD 202.5 Bn by 2022, expanding at a CAGR of 2.7% from 2016 to 2022.
Browse the full report Novel Drug Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/novel-drug-delivery-systems-ndds-market
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the market in terms of revenue (USD). The key factors assisting the growth of liposomes market are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs.
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/pharmaceuticals-market
Market Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Key Market Movements:
North America is expected to lead the global novel drug delivery systems market due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
Projected market entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems market are expected to provide an exceptional growth to the market.
Novel drug delivery systems market is expected to intensify the market competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition.
Blog URL - http://www.mobilecomputingtoday.co.uk/3741/global-novel-drug-delivery-systems-ndds-market-valued-usd-165-4-2015-credence-research/
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
For More Information, Visit: http://www.credenceresearch.com/
Company Name: Credence Research
Contact Person: Chris Smith,
Designation: Global Sales Manager
Address: 105 N 1st ST #429, San Jose,